throbber
MYLAN EXHIBIT - 1012 (Part 4)
`Mylan Pharmaceuticals, Inc. v. Bausch Health Ireland, Ltd. -
`
`

`

`Chapter 7 Protein Function
`
`227
`
`The class I MHC protein—peptide complexes on infected cells are rec-
`ognized as foreign and bound by those T,, cells with T-cell receptors having
`the appropriate binding specificity. The T-cell receptors respond only to
`peptide antigens that are complexed to class | MHC proteins. The T; cells
`have an additional receptor, CD8, also called a coreceptor, that enhances
`the binding interactions of T-cell receptors and MHCproteins (Fig. 7-22,
`middle left). The T, cells live up to the namekiller T cells by destroying the
`virally infected cell to which they are complexed through their T-cell re-
`ceptors. Cell death is brought about by a number of mechanisms, not all
`well understood. One mechanism involves the release of a protein called
`perforin, which binds to and aggregates in the plasma membraneof the
`target cell, forming molecular pores that destroy the capacity of that cell
`to regulate its interior environment. T, cells also induce a process called
`programmed cell death, or apoptosis (most commonly pronounced
`app’-a-toe’-sis), in which the cells complexed to T, cells undergo metabolic
`changes that rapidly lead to the demise of the cell.
`T. cells with the proper specificity must proliferate selectively if large
`numbers of virus-infected cells are to be destroyed. To this end, Te cells
`complexed to an infected cell generate cell-surface receptors for signaling
`proteins called interleukins. Interleukins, secreted by a variety of cells,
`stimulate the proliferation of only those T and B cells bearing the required
`interleukin receptors. Because T and B cells produceinterleukin receptors
`only when they are complexed with an antigen, the only immune system
`cells that proliferate are those few that can respond to the antigen. The
`process of producing a population of cells by stimulated reproduction of a
`particular ancestorcell is called clonal selection.
`The peptides complexed to class II MHC proteins and displayed on the
`surface of macrophages and B lymphocytes are similarly bound by the ap-
`propriate T-cell receptors of T,, cells. The T} cells also have a coreceptor,
`called CD4, that enhances the binding interactions of the T-cell receptors.
`This overall binding interaction, in concert with secondary molecularsig-
`nals that are currently being identified, activates the T,, cells. A subpopula-
`tion of activated T,, cells secrete a small signal protein called interleukin-2
`(IL-2; M, 15,000), which stimulates proliferation of nearby T, cells and Ty
`cells having the appropriate interleukin receptors. This greatly increases
`the numberof available immune system cells capable of recognizing and re-
`sponding to the antigen. Another subpopulation of activated T, cells com-
`plexed to macrophages or B lymphocytes secrete interleukin-4 (IL-4; /,
`20,000), which stimulates the proliferation of B cells that recognize the
`antigen (Fig. 7-22, bottom right). Proliferation of the responding B, Ty, and
`Ty cells continues as long as the appropriate antigen is present.
`The proliferating B cells promote the destruction of any extracellular
`viruses or bacterial cells. They first secrete large amounts of soluble anti-
`body that binds to the antigen. This bound antibody recruits a cellular sys-
`tem of about 20 proteins collectively called complement because they com-
`plement and enhancethe actionof the antibodies. The complement proteins
`disrupt the coats of many virusesor, in bacterial infections, produce holes in
`the cell walls of bacteria, causing them to swell and burst by osmotic shock.
`Unlike T cells, B cells do not undergo selection in the thymusto elimi-
`nate those producing antibodies that recognize host (self) proteins. How-
`ever, B cells do not contribute significantly to an immune response unless
`they are stimulated to proliferate by T,, cells. The T, cells do undergo se-
`lection in the thymus, leaving no T, cells capable of stimulating B cells that
`produce antibodies potentially dangerous to the host.
`The Ty cells themselves participate only indirectly in the destruction of
`infected cells and pathogens, buttheir role is critical to the entire immune
`
`
`
`

`

`228
`
`Part || Structure and Catalysis
`
`response. This is dramatically illustrated by the epidemic produced by HIV
`(human immunodeficiency virus), the virus that causes AIDS (acquired im-
`mune deficiency syndrome). The primary targets of HIV infection are Ty
`cells. Elimination of these cells progressively incapacitates the entire im-
`mune system.
`Once antigen is depleted,activated immunecells generally die in a mat-
`ter of days by programmed cell death. However, a few of the stimulated B
`and T cells mature into memory cells. These are long-lived cells that do
`notparticipate directly in the primary immune response when the antigen
`is first encountered. Instead they become permanentresidentsof the blood,
`ready to respond to a reappearance of the same antigen. Memory cells,
`when subsequently challenged by the antigen, can mount a secondary im-
`mune response that is generally much more rapid and vigorous than the
`primary response because of prior clonal expansion. By this mechanism,
`vertebrates once exposed to a virus or other pathogen can respond quickly
`to the pathogen when exposed again. This is the basis of the long-term im-
`munity conferred by vaccines and the natural immunity to repeated infec-
`tions by the samestrain of a virus.
`
`figure 7-23
`The structure of immunoglobulin G. (a) Pairs of heavy
`and light chains combine to form a Y-shaped molecule.
`Two antigen-binding sites are formed by the combination
`of variable domains from onelight (V,) and one heavy
`(V4) chain. Cleavage with papain separates the Fab and
`Fe portions of the protein in the hinge region. The Fe
`portion of the molecule also contains bound carbo-
`hydrate. (b) A ribbon model of the first cornplete IgG
`molecule to be crystallized and structurally analyzed.
`Although the molecule contains two identical heavy
`chains (two shades of blue) and two identical light chains
`(two shadesof red), it crystallized in the asymmetric con-
`formation shown. Conformational flexibility may be impor-
`tant to the function of immunoglobulins.
`
`Antigen-
`binding
`site
`/
`Papain
`hays /
`cleavage
`
`sites=Vy f Ne
`
`Antibodies Have Two Identical Antigen-Binding Sites
`Immunoglobulin G (IgG) is the major class of antibody molecule and one
`of the most abundantproteins in the blood serum. IgG has four polypeptide
`chains: two large ones, called heavy chains, and twolight chains, linked by
`noncovalent and disulfide bonds into a complex of M, 150,000. The heavy
`chains of an IgG molecule interact at one end, then branch to interact sep-
`arately with the light chains, forming a Y-shaped molecule (Fig. 7-23). At
`the “hinges” separating the base of an IgG molecule fromits branches, the
`immunoglobulin can be cleaved with proteases. Cleavage with the protease
`papain liberates the basal fragment, called Fe becauseit usually crystallizes
`readily, and the two branches, which are called Fab, the antigen-binding
`
`fragments, Each branchhas a single antigen-bindingsite.
`
`
`
`
`
`Cyl
`
`A
`
`fee : Aee C%
`
`ous
`
`cog”
`
`C = constant domain
`V = variable domain
`
`H, L = heavy,light chains
`
`(a)
`
`

`

`The fundamental structure of immunoglobulins wasfirst established by
`Gerald Edelman and Rodney Porter. Each chain is made up of identifiable
`domains; some are constant in sequence andstructure from one IgG to the
`next, others are variable. The constant domains have a characteristic struc-
`ture known as the immunoglobulin fold, a well-conserved structural mo-
`tif in the all-@ class. There are three of these constant domains in each
`heavy chain and onein each light chain. The heavy and light chains also
`have one variable domain each, in which most of the variability in amino
`acid residue sequenceis found. The variable domains associate to create
`the antigen-binding site (Fig. 7-24).
`
`Chapter 7 Protein Function
`
`229
`
`figure 7-24
`Binding of IgG to an antigen. To generate an optimal
`fit for the antigen, the binding sites of IgG often undergo
`slight conformational changes. Such inducedfit is
`common to manyprotein-ligand interactions.
`
`~ooc
`
`coo
`
`Antibody
`
`Antigen-antibody complex
`
`In many vertebrates, IgG is only oneoffive classes of immunoglobulins.
`Fachclass has a characteristic type of heavy chain, denoted a, 6, e, y, and
`uw for IgA, IgD, IgE, IgG, and IgM, respectively. Two types of light chain,
`x and X, occur in all classes of immunoglobulins. The overall structures of
`IgD and IgE are similar to that of IgG. IgM occurs in either a monomeric,
`membrane-bound form or a secreted form that is a cross-linked pentamer
`of this basic structure (Fig. 7-25). IgA, found principally in secretions such
`as saliva, tears, and milk, can be a monomer, dimer, or trimer. [gM is the first
`antibody to be made by B lymphocytes and is the major antibody in the
`early stages of a primary immuneresponse. Some B cells soon begin to pro-
`duce IgD (with the same antigen-binding site as the IgM produced by the
`same cell), but the unique function of IgD is less clear.
`
`pu Heavy
`
` Boe
`chains
`
`figure 7-25
`IgM pentamer of immunoglobulin units. The pentamer
`is cross-linked with disulfide bonds. The J chain is a
`polypeptide of M, 20,000 found in both IgA and IgM.
`
`
`
`

`

`230
`
`Part Il Structure and Catalysis
`
`The IgG described aboveis the major antibody in secondary immunere-
`sponses, which are initiated by memory B cells. As part of the organism's
`ongoing immunity to antigens already encountered and dealt with, IgG is
`the most abundant immunoglobulin in the blood. When IgG binds to an in-
`vading bacterium or virus, it not only activates the complement system, but
`also activates certain leukocytes such as macrophagesto engulf and destroy
`the invader. Yet anotherclass of receptors onthecell surface of macrophages
`recognizes and binds the Fc region of IgG. When these Fc receptors bind an
`antibody-pathogen complex,
`the macrophage engulfs the complex by
`phagocytosis (Fig. 7-26).
`
`figure 7-26
`Phagocytosis of an antibody-bound virus by a
`macrophage. The Fc regions of the antibodies bind to Fc
`receptors on the surface of the macrophage, triggering
`the macrophage to engulf and destroy the virus.
`
`virus
`
`
`
`Phagocytosis
`>
`
`Macrophage
`
`IgG-coated
`
`Fe region
`of IgG
`
`
`
`IgG Fe
`receptor
`
`IgE plays an importantrole in the allergic response,interacting with ba-
`sophils (phagocytic leukocytes) in the blood and histamine-secreting cells
`called mast cells that are widely distributed in tissues. This immunoglobu-
`lin binds, throughits Fe region, to special Fc receptors on the basophils or
`mast cells. In this form, IgE serves as a kind of receptor for antigen.If anti-
`gen is bound,the cells are induced to secrete histamine and otherbiologi-
`cally active amines that cause dilation and increased permeability of blood
`vessels. These effects on the blood vessels are thought to facilitate the
`movement of immune system cells and proteins to sites of inflammation.
`They also produce the symptoms normally associated with allergies. Pollen
`or other allergens are recognizedas foreign, triggering an immune response
`normally reserved for pathogens.
`
`Antibodies Bind Tightly and Specifically to Antigen
`The binding specificity of an antibody is determined by the amino acid
`residuesin the variable domainsof its heavy and light chains. Many residues
`in these domains are variable, but not equally so. Some, particularly those
`lining the antigen-bindingsite, are hypervariable—especially likely to differ.
`Specificity is conferred by chemical complementarity between the antigen
`and its specific bindingsite, in terms of shape andthe location of charged,
`nonpolar, and hydrogen-bonding groups. For example, a bindingsite with a
`negatively charged group may bind an antigen with a positive charge in the
`complementary position. In many instances, complementarity is achieved
`interactively as the structures of antigen and binding site are influenced by
`each other during the approach of the ligand. Conformational changes in
`the antibody and/or the antigen then occur that allow the complementary
`groups tointeract fully. This is an example of induced fit (Fig. 7-27).
`
`

`

`Chapter 7
`
`Protein Function
`
`231
`
`
`
`Conformation with
`no antigen bound
`(a)
`
`Antigen bound
`(hidden)
`(b)
`
`Antigen bound
`(shown)
`(c)
`
`A typical antibody-antigen interaction is quite strong, characterized by
`K, values as low as 10°"” m (recall that a lower K, corresponds to a stronger
`binding interaction). The Ky reflects the energy derived from the various
`ionic, hydrogen-bonding, hydrophobic, and van der Waals interactions that
`stabilize the binding. The binding energy required to produce a Ky of 107" m
`is about 65 kJ/mol.
`A complex of a peptide derived from HIV (a model antigen) and an Fab
`molecule illustrates some of these properties (Fig. 7-27). The changes in
`structure observed on antigen binding are particularly striking in this example.
`
`figure 7-27
`Induced fit in the binding of an antigen to IgG. The
`molecule, shown in surface contour, is the Fab fragment
`of an IgG. The antigen this IgG binds is a small peptide
`derived from HIV. Two residues from the heavy chain
`(blue) and one from the light chain (pink) are colored to
`provide visual points of reference. (a) View of the Fab
`fragment looking down on the antigen-binding site.
`(b) The same view, but here the Fab fragmentis in the
`“bound” conformation; the antigen has been omitted
`from the image to provide an unobstructed view of the
`altered binding site. Note how the binding cavity has
`enlarged and several groups have shifted position.
`(c) The same view as in (b), but with the antigen pictured
`in the binding site as a red stick structure.
`
`The Antibody-Antigen Interaction Is the Basis for a Variety
`of Important Analytical Procedures
`The extraordinary binding affinity and specificity of antibodies makes them
`valuable analytical reagents. Two types of antibody preparations are in use:
`polyclonal and monoclonal. Polyclonal antibodies are those produced by
`many different B lymphocytes responding to one antigen, such as a protein
`injected into an animal. Cells in the population of B lymphocytes produce
`antibodies that bind specific, different epitopes within the antigen. Thus,
`polyclonal preparations contain a mixture of antibodies that recognize dif-
`ferent parts of the protein. Monoclonal antibodies, in contrast, are syn-
`thesized by a population ofidentical B cells (a clone) grown in cell culture.
`These antibodies are homogeneous,all recognizing the same epitope. The
`techniques for producing monoclonal antibodies were developed by
`Georges Kohler and Cesar Milstein.
`The specificity of antibodies has practical uses. A selected antibody can
`be covalently attached to a resin and used in a chromatography column of
`the type shown in Figure 5—18c. When a mixture of proteinsis addedto the
`column,the antibody will specifically bind its target protein and retain it on
`the column while other proteins are washed through. The target protein can
`then be eluted from theresin by a salt solution or some other agent. This is
`a powerful tool for protein purification.
`In another versatile analytical technique, an antibody is attached to a
`radioactive label or some other reagent that makes it easy to detect. When
`the antibody binds the target protein, the label reveals the presence of the
`protein in a solution or its location in a gel or evenaliving cell. Several
`Cesar Milstein
`variations of this procedure are illustrated in Figure 7-28.
`
`
`Georges Kohler
`
`

`

`232
`
`Part Il
`
`Structure and Catalysis
`
`An ELISA (enzyme-linked immunosorbent assay) allows for rapid
`screening and quantification of the presence of an antigen in a sample (Fig.
`7-28b). Proteins in a sample are adsorbed to an inert surface, usually a
`96-well polystyrene plate. The surface is washed with a solution of an inex-
`pensive nonspecific protein (often casein from nonfat dry milk powder) to
`block proteins in subsequentsteps from also adsorbing to these surfaces. The
`surface is then treated with a solution containing the primary antibody—
`an antibody against the protein of interest. Unbound antibody is washed
`away and the surfaceis treated with a solution containing antibodies against
`the primary antibody. These secondary antibodies have been linked to an
`enzyme that catalyzes a reaction that forms a colored product. After un-
`bound secondary antibody is washed away, the substrate of the antibody-
`linked enzyme is added. Product formation (monitored as color intensity)
`is proportional to the concentration of the proteinof interest in the sample.
`In an immunoblot assay (Fig. 7-28c), proteins that have been sepa-
`rated by gel electrophoresis are transferred electrophoretically to a nitro-
`cellulose membrane. The membrane is blocked (as described above for
`ELISA), then treated successively with primary antibody, secondary anti-
`body linked to enzyme, and substrate. A colored precipitate forms only
`along the band containing the protein of interest. The immunoblot allows
`
`figure 7-28
`Antibody techniques. The specific reaction of an anti-
`body with its antigen is the basis of several techniques
`that identify and quantify a specific protein in a complex
`sample. (a) A schematic representation of the general
`method. (b) An ELISA testing for the presence of herpes
`simplex virus (HSV) antibodies in blood samples. Wells
`were coated with an HSV antigen, to which antibodies
`against HSV in a patient's blood will bind. The second
`antibody is anti-human IgG linked to horseradish peroxi-
`dase. Blood samples with greater amounts of HSV anti-
`body turn brighter yellow. (c) An immunoblot. Lanes 1 to
`3 are from an SDSgel; samples from successive stagesin
`the purification of a protein kinase have been separated
`and stained with Coomassie blue. Lanes 4 to 6 show the
`same samples, but these were electrophoretically trans-
`ferred to a nitrocellulose membraneafter separation on
`an SDS gel. The membrane was then “probed” with anti-
`body against the protein kinase. The numbers between
`the gel and the immunoblot indicate M, (x 1073).
`
`
`of specific antigen.
`
`
`
`@ Coat surface with sampleJ& &
`(antigens).
`
`(2) Block unoccupied sites
`with nonspecific protein.
`
`8) Incubate with primary
`antibody against specific
`antigen.
`
`(4) Incubate with
`antibody-enzyme complex
`that binds primary antibody.
`
`® Add substrate.
`
`©) Formationof colored

`product indicates presence %
`
`(a)
`
`-215-
`
`-14.4 -
`
`ELISA assay
`(b)
`
`SDSgel
`
`Immunoblot
`
`(c)
`
`

`

`Chapter 7 Protein Function
`
`233
`
`the detection of a minor component in a sample and provides an approxi-
`mation of its molecular weight.
`We will encounter other aspects of antibodies in later chapters. They
`are extremely important in medicine and can tell us much about the struc-
`ture of proteins and the action of genes.
`
`Two supercoiled,Amino
`a nenee
`ao
`
`(a)
`
`z
`
`Myosin
`
`-
`
`Protein Interactions Modulated by Chemical Energy:
`Actin, Myosin, and Molecular Motors
`Organisms move. Cells move. Organelles and macromolecules within cells
`move. Most of these movements arise from the activity of the fascinating
`class of protein-based molecular motors. Fueled by chemical energy, usually
`derived from ATP, large aggregates of motor proteins undergo cyclic con-
`formational changes that accumulate into a unified, directional force—the
`tiny force that pulls apart chromosomes in a dividing cell, and the immense
`“Tail
` 150 nm
`force that levers a pouncing, quarter-ton jungle cat into the air.
`:
`The interactions among motor proteins, as you might predict, feature
`complementary arrangements of ionic, hydrogen-bonding, hydrophobic, ys terminus
`and van der Waals interactions at protein binding sites. In motor proteins,
`,
`however, these interactions achieve exceptionally high levels of spatial and
`temporal organization.
`Motor proteins underlie the contraction of muscles, the migration ofor-
`ganelles along microtubules, the rotation of bacterial flagella, and the move-
`ment of some proteins along DNA. As we noted in Chapter2, proteins called
`kinesins and dyneins move along microtubules in cells, pulling along or-
`ganelles or reorganizing chromosomesduring cell division (see Fig. 2-19).
`An interaction of dynein with microtubules brings about the motion of eu-
`karyotic flagella andcilia. Flagellar motion in bacteria involves a complex
`rotational motor at the base of the flagellum (see Fig. 19-32). Helicases,
`polymerases, and other proteins move along DNA as they carry out their
`functions in DNA metabolism (Chapter 25). Here, we focus on the well-
`studied example of the contractile proteins of vertebrate skeletal muscle as
`a paradigm for how proteins translate chemical energy into motion.
`
`
`
`
`Lath
`
`Light
`meromyosin
`
`=
`=
`
`Hayy
`meromyosin
`+ Bee
`
`Ko53o =(eas
`LL! S
`
`(b)
`
`$2
`
`The Major Proteins of Muscle Are Myosin and Actin
`
`Thecontractileforceofmuscleisgeneratedbytheinteractionoftwoproteins,
`
`myosin and actin. These proteins are arranged in filaments that undergo
`transient interactions and slide past each other to bring about contraction.
`Together, actin and myosin make up over 80% of the protein mass of muscle.
`Myosin (, 540,000) has six subunits: two heavy chains (M, 220,000)
`and four light chains (M, 20,000). The heavy chains account for much of
`the overall structure. At their carboxyl termini, they are arranged as ex-
`tended @ helices, wrapped around each other in a fibrous, left-handed
`coiled coil similar to that of a-keratin (Fig. 7-29a). At its amino termini,
`each heavy chain hasa large globular domain containing a site where ATP
`is hydrolyzed. The light chains are associated with the globular domains.
`
`
`
`
`
` figure 7-29
`
`Myosin. (a) Myosin has two heavy chains(in two shadesof
`pink), the carboxyl termini forming an extended coiled coil
`(tail) and the amino termini having globular domains (heads).
`Twolight chains (blue) are associated with each myosin
`head. (b) Cleavage with trypsin and papain separates the
`myosin heads (S1 fragments) from the tails. (c) Ribbon rep-
`resentation of the myosin S1 fragment. The heavy chain is
`in gray, the twolight chains in two shadesof blue.
`
`

`

`234
`
`Part ||
`
`Structure and Catalysis
`
`figure 7-30
`The major components of muscle. (a) Myosin aggre-
`gates to form a bipolar structure called a thick filament.
`(b) F-actin is a filamentous assemblage of G-actin
`monomers that polymerize two by two, giving the appear-
`anceof twofilaments spiraling about one anotherin a
`right-handed fashion. An electron micrograph and a
`model of F-actin are shown. (c) Space-filling model of an
`actin filament (red) with one myosin head (gray and two
`shades of blue) bound to an actin monomerwithin the
`filament.
`
`
`
`When myosin is treated briefly with the protease trypsin, much of the fi-
`broustail is cleaved off, dividing the protein into componentscalled light
`and heavy meromyosin (Fig. 7-29b). The globular domain, called myosin
`subfragment 1, or S1, or simply the myosin head group, is liberated from
`heavy meromyosin by cleavage with papain. The S1 fragment produced by
`this procedureis the motor domain that makes muscle contraction possible.
`S1 fragments can be crystallized, and their structure has been determined,
`The overall structure of the S1 fragment as determined by Ivan Rayment
`and Hazel Holdenis shown in Figure 7-29c.
`In muscle cells, molecules of myosin aggregate to form structures called
`thick filaments (Fig. 7-30a). These rodlike structures serve as the core of
`the contractile unit. Within a thick filament, several hundred myosin mole-
`cules are arranged with their fibrous “tails” associated to form a long bipo-
`lar structure. The globular domains project from either end of this struc-
`ture, in regular stacked arrays.
`The second major muscle protein, actin, is abundantin almost all eu-
`karyotic cells. In muscle, molecules of monomeric actin, called G-actin
`(globular actin; M, 42,000), associate to form a long polymer called F-actin
`(filamentousactin). The thin filament (Fig. 7-30b) consists of F-actin,
`along with the proteins troponin and tropomyosin. The filamentous parts of
`thin filaments assemble as successive monomeric actin molecules add to
`one end. On addition, each monomerbinds ATP, then hydrolyzes it to ADP,
`so all actin molecules in the filament are complexed to ADP. However, this
`ATP hydrolysis by actin functions only in the assembly ofthe filaments; it
`does not contribute directly to the energy expended in muscle contraction.
`Each actin monomerin the thin filament can bindtightly and specifically to
`one myosin head group (Fig. 7—30c).
`
`Myosin head
`
`Actin filament
`
`(c)
`
`
`
`
`G-actin
`subunits
`
`(b)
`
`

`

`Chapter 7
`
`Protein Function
`
`235
`
`Additional Proteins Organize the Thin and Thick Filaments
`into Ordered Structures
`Skeletal muscle consists of parallel bundles of muscle fibers, each fiber a
`single, very large, muleinuciested eel, 20 to age aon im diameter, formed
`from many cells fused together and often spanning the length of the mus-
`cle. Hach fiber, in turn, contains about 1,000 myofibrils, 2 »m in diameter,
`each consisting of a vast number of regularly arrayed thick and thin fila-
`ments complexed to other proteins (Fig. 7-31). A system of flat membra-
`nousvesicles called the sarcoplasmic reticulum surrounds each myofib-
`ril. Examined under
`the electron microscope, muscle fibers
`reveal
`5
`:
`P ty
`alternating regions of high and low electron density, called the A and I
`bands (Fig. 7-31b,c). The A and I bandsarise from the arrangement of
`
`figure 7-31
`Structure of skeletal muscle. (a) Muscle fibers consist of
`ingle, elongated, multinucleatedcells that arise from the
`fusion of many precursorcells. Within the fibers are many
`myofibrils (only six are shown here for simplicity) sur-
`founded by the membranoussarcoplasmic reticulum.
`_‘"he organizationof thick andthin filaments in the
`Finer Biss a Sis annetate Yee
`contracts, the | bands narrow and the Z disks come
`closer together, as seen in electron micrographsof
`relaxed (b) and contracted (ce) muscle.
`
`(a)
`
`Bundle of
`muscle fibers
`
`Myofibrils
`
`Capillaries
`
`"a
`Muscle Fiber
`
`
`
`Sarcoplasmic
`:
`reticulum
`
`Sarcomere
`
`I band
`
`A band
`
`
`
`
`
`
`
`Z disk
`
`M line
`
`1.8 «m
`
`Z disk
`
`M line
`
`Z disk
`
`

`

`236
`
`Part || Structure and Catalysis
`
`thick and thin filaments, which are aligned and partially overlapping. The I
`band is the region of the bundle that in cross section would contain only
`thin filaments. The darker A band stretches the length of the thick filament
`and includes the region where parallel thick and thin filaments overlap. Bi-
`secting the I band is a thin structure called the Z disk, perpendicular to the
`thin filaments and serving as an anchor to which the thin filaments are at-
`tached. The A bandtoo is bisected by a thin line, the M line or M disk, a
`region of high electron density in the middle of the thick filaments. The en-
`tire contractile unit, consisting of bundles of thick filaments interleaved at
`either end with bundles of thin filaments, is called the sarcomere. The
`arrangement of interleaved bundles allows the thick and thin filaments to
`slide past each other (by a mechanismdiscussed below), causing a pro-
`gressive shortening of each sarcomere (Fig. 7-32).
`The thin actin filaments are attached at one end to the Z disk in a reg-
`ular pattern. The assembly includes the minor muscle proteins e-actinin,
`desmin, and vimentin. Thin filaments also contain a large protein called
`nebulin (~7,000 amino acid residues), thought to be structured as an
`a helix long enough to span the length of the filament. The Mline similarly
`
`band
` Z disk
`
`figure 7-32
`Muscle contraction. Thick filaments are bipolar struc-
`tures created by the association of many myosin mole-
`cules. (a) Muscle contraction occurs by the sliding of the
`thick and thin filaments past each other so that the Z
`disks in neighboring | bands approach each other.
`(b) The thick and thin filaments are interleaved such that
`eachthick filament is surrounded bysix thin filaments.
`
`band
`
`Thin
`filament
`
`B— Thick
`filament
`
`A
`bandee—"*K,
`=
`
`I
`
`Contracted
`
`(a)
`
`(b)
`
`

`

`Chapter 7 Protein Function
`
`237
`
`
`
`filament
`
`
`
`Myosin
`thick
`filament
`
`
`‘
`ATPbinds to myosin head,

`|
`causingdissociation
`
`from actin.
`
` ;
`
`@)
`
`As tightly bound ATPis hydrolyzed,
`a conformational change occurs.
`ADPand P; remain associated
`with the myosin head.
`
`i
`i
`
`
`
`
`
`
` 4
`
`
`
`@
`
`Pi
`
`Myosin head attaches
`to actin filament,
`causingreleaseofPj.
`
`
`
`(4)
`
`i
`
`ADP @ |
`
`P, release triggers a "powerstroke,"
`a conformational change in the myosin
`filaments relative to one another.
`ADPis released in the process.
`
`head that moves actin and myosin
`
`organizes the thick filaments. It contains the proteins paramyosin, C-pro-
`tein, and M-protein. Another class of proteins called titins, the largest
`known single polypeptide chains (the titin of human cardiac muscle has
`26,926 amino acid residues), link the thick filaments to the Z disk, providing
`additional organization to the overall structure. Among their structural
`functions, the proteins nebulin and titin are believed to act as “molecular
`rulers,” regulating the length of the thin and thick filaments, respectively.
`Titin extends from the Z disk to the M line, regulating the length of the sar-
`comere itself and preventing overextension of the muscle. The characteris-
`tic sarcomere length varies from one muscle tissue to the next in a verte-
`brate organism, attributed in large part to the expression of different titin
`variants.
`
`Myosin Thick Filaments Slide along Actin Thin Filaments
`The interaction between actin and myosin, like that betweenall proteins
`and ligands, involves weak bonds. When ATP is not bound to myosin, a face
`on the myosin head group bindstightly to actin (Fig. 7-33). When ATP binds
`to myosin and is hydrolyzed to ADP and phosphate, a coordinated and
`cyclic series of conformational changes occur in which myosin releases the
`F-actin subunit and binds another subunit farther along the thin filament.
`The cycle has four major steps (Fig. 7-33). @) ATP binds to myosin,
`and a cleft in the myosin molecule opens, disrupting the actin-myosin inter-
`action so that the bound actin is released. ATP is then hydrolyzed (step Q),
`causing a conformational change in the protein to a “high-energy”state that
`moves the myosin head and changesits orientation in relation to the actin
`thin filament. Myosin then binds weakly to an F-actin subunit closer to the
`Z disk than the one just released. As the phosphate product of ATP hydrol-
`ysis is released from myosinin step @), another conformational change oc-
`curs in which the myosin cleft closes, strengthening the myosin-actin bind-
`ing. This is followed quickly by the final step, (4), a “power stroke” during
`which the conformation of the myosin head returns to the original resting
`state, its orientation relative to the bound actin changing so as to pull the
`tail of the myosin toward the Z disk. ADP is then released to complete the
`cycle. Each cycle generates about 3 to 4 pN (piconewtons) of force and
`moves the thick filament 5 to 10 nm relative to the thin filament.
`Because there are many myosin headsin a thick filament, at any given
`moment some (probably 1% to 3%) are bound to the thin filaments. This
`prevents the thick filaments from slipping backward when an individual
`myosin head releases the actin subunit to which it was bound. Thethickfil-
`ament thus actively slides forward past the adjacent thin filaments. This
`process, coordinated among the many sarcomeres in a muscle fiber, brings
`about muscle contraction.
`The interaction between actin and myosin must be regulated so that
`contraction occurs only in response to appropriate signals from the nervous
`
`figure 7-33
`Molecular mechanism of muscle contraction. Conforma-
`tional changes in the myosin head that are coupled to
`stages in the ATP hydrolytic cycle cause myosin to suc-
`cessively dissociate from one actin subunit, then asso-
`ciate with another farther along the actin filament. In this
`way the myosin heads slide along the thin filaments,
`drawing the thick filament array into the thin filament
`array (see Fig. 7-32).
`
`

`

`238
`
`Part || Structure and Catalysis
`
`system. The regulation is mediated by a complex of two proteins,
`tropomyosin and troponin. Tropomyosin binds to the thin filament,
`blocking the attachment sites for the myosin head groups. Troponin is a
`Ca”*-binding protein. A nerve impulse causes release of Ca2* from the sar-
`coplasmic reticulum. The released Ca** binds to troponin (another protein-
`ligand interaction) and causes a conformational change in the tropomyosin-
`troponin complexes, exposing the myosin-binding sites on the thin
`filaments. Contraction follows.
`Working skel

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket